AZDDQ yields 2000000.00% · PFE yields 6.13%● Live data
📍 AZDDQ pulled ahead of the other in Year 1
Combined, AZDDQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AZDDQ + PFE for your $10,000?
Azure Dynamics Corporation engages in the development and supply of electric and hybrid electric power trains and vehicle control systems for light and heavy duty commercial vehicles in North America. The company's hybrid electric vehicle systems include an electric motor, energy storage system, and additional power source, such as internal combustion engine/generator; and electric vehicle systems comprising electric motor and an energy storage system. The company offers series and parallel hybrid power train products comprising stripped hybrid chassis for general delivery vans, and a cutaway hybrid chassis for shuttle buses and other vocational trucks; and low emission electric power freeze and lift systems for refrigeration, utility, and telecom truck applications. It also integrates Force Drive electric powertrain auxiliaries and battery packs, as well as sells the battery electric transit connects. In addition, the company provides electric drive systems, as well as electric drive components comprising AC motors, inverters, converters, controllers, battery chargers, and gear boxes. It has operations in Canada, the United States, the United Kingdom, and other countries. The company was incorporated in 1993 and is headquartered in Oak Park, Michigan. Azure Dynamics Corp. is in reorganization.
Full AZDDQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.